[1] G A POTTER. The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1[J]. British Journal of Cancer, 2002, 86 5: 774-778. DOI:
10.1038/sj.bjc.6600197[2] VIRGINIE AUMONT . Regioselective and Stereospecific Glucuronidation of trans- and cis-Resveratrol in Human[J]. Archives of biochemistry and biophysics, 2001, 393 2: Pages 281-289. DOI:
10.1006/abbi.2001.2496[3] BARBARA CALAMINI. Pleiotropic mechanisms facilitated by resveratrol and its metabolites.[J]. Biochemical Journal, 2010, 429 2: 273-282. DOI:
10.1042/bj20091857[4] ELENA POLYCARPOU. Resveratrol 3-O-d-glucuronide and resveratrol 4′-O-d-glucuronide inhibit colon cancer cell growth: Evidence for a role of A3 adenosine receptors, cyclin D1 depletion, and G1 cell cycle arrest[J]. Molecular Nutrition & Food Research, 2013, 57 10: 1708-1717. DOI:
10.1002/mnfr.201200742[5] MELLINA S. SIM?ES . Resveratrol biotransformation and actions on the liver metabolism of healthy and arthritic rats[J]. Life sciences, 2022, 310: Article 120991. DOI:
10.1016/j.lfs.2022.120991